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LGR5 is a known marker of embryonic and adult stem cells in several tissues. In a mouse model, Lgr5þ
cells have shown tumour-initiating properties, while in human cancers, such as basal cell carcinoma and
colon cancer, LGR5 expression levels are increased: however, the effect of increased LGR5 expression is
not fully understood. To study the effects of elevated LGR5 expression levels we generated a novel tet-
racycline-responsive, conditional transgenic mouse line expressing human LGR5, designated TRELGR5. In
this transgenic line, LGR5 expression can be induced in any tissue depending on the expression pattern of
the chosen transcriptional regulator. For the current study, we used transgenic mice with a tetracycline-
regulated transcriptional transactivator linked to the bovine keratin 5 promoter (K5tTA) to drive
expression of LGR5 in the epidermis. As expected, expression of human LGR5 was induced in the skin of
double transgenic mice (K5tTA;TRELGR5). Inducing LGR5 expression during embryogenesis and early
development resulted in macroscopically and microscopically detectable phenotypic changes, including
kink tail, sparse fur coat and enlarged sebaceous glands. The fur and sebaceous gland phenotypes were
reversible upon discontinued expression of transgenic LGR5, but this was not observed for the kink tail
phenotype. There were no apparent phenotypic changes if LGR5 expression was induced at three weeks
of age. The results demonstrate that increased expression of LGR5 during embryogenesis and the neo-
natal period alter skin development and homeostasis.
& 2015 Elsevier Inc. All rights reserved.Introduction
The leucine-rich, repeat-containing G protein coupled receptor
5 (Lgr5) contains 907 amino acids and is well conserved (86%
identity and 91% similarity) between mice and humans. It was
originally identiﬁed as a Wnt/Tcf4 target gene expressed in colon
cancer (Van der Flier et al., 2007). More recently, Lgr5 was shown
to be a stem cell marker in multiple tissues, including stomach,
small intestine, colon, hair follicle, mammary gland, cochlea, kid-
ney and incisor (Barker et al., 2010, 2012, 2007; Chai et al., 2012;
de Visser et al., 2012; Jaks et al., 2008; Suomalainen and Thesleff,
2010). Lineage tracing experiments have shown that Lgr5þ stem
cells have the potential to generate all epithelial cell lineages ofand Cancer Stem Cell Inno-
iversity Hospital, Norwegian
um).the hair follicle (HF) under certain conditions, and of the small
intestine during normal tissue homeostasis (Barker et al., 2010,
2012, 2007; Chai et al., 2012; de Visser et al., 2012; Jaks et al.,
2008; Suomalainen and Thesleff, 2010). Actively proliferating
Lgr5þ cells reside in the lower part of the HF where they exhibit
the characteristics of a multipotent stem cell population respon-
sible for maintaining this region. Upon wounding, these cells are
able to give rise to new HFs containing all epithelial HF cell
lineages (Jaks et al., 2008). However, Lgr5þ stem cells do not
contribute to the development of the sebaceous gland (SG) or
interfollicular epidermis (IFE). In postnatal mice, Lgr6þ and
Lrig1þ labelled stem cell populations have been assigned roles in
maintaining the SG (Page et al., 2013; Snippert et al., 2010).
Recently, R-spondins (RSPOs) were identiﬁed as ligands for
LGR4–LGR6 receptors (Carmon et al., 2011; de Lau et al., 2011).
Binding of RSPOs to the LGR5 receptor enhances canonical Wnt/β-
catenin signalling by increasing Wnt-dependant phosphorylation
of the Frizzled co-receptor, LRP6. In addition, LGR5 receptors have
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as Wnt/PCP (planar cell polarity) signalling (Glinka et al., 2011).
Wnt/PCP signalling is independent of β-catenin and results in the
activation of Rho and then of the Rho-associated kinase (ROCK)
(Habas et al., 2003). In Xenopus embryos, Rspo3 enhances both
Wnt/β-catenin and Wnt/PCP signalling (Ohkawara and Niehrs,
2011). Furthermore, Wnt/PCP signalling was shown to be depen-
dant on Lgr4 and Lgr5 in Xenopus embryos (Glinka et al., 2011).
The importance of Wnt signalling in skin and HF development
has been demonstrated by the expression of Dickkopf (Dkk), a Wnt
signalling inhibitor, in the basal epithelium resulting in a failure to
form hair, vibrissae, teeth and mammary glands (Andl et al., 2002).
The conditional knockout of β-catenin in basal keratinocytes
showed that β-catenin is required for the initial development of
the hair placode as well as in the catagen phase of the hair cycle
(Huelsken et al., 2001). Inhibition of Wnt/β-catenin signalling in
mouse K14þ keratinocytes resulted in gradual hair loss from the
age of 6 weeks and tumours originating from both the base of the
HF and sebaceous gland (Niemann et al., 2002). Interestingly,
increased Wnt/β-catenin signalling in the skin also resulted in de
novo hair morphogenesis and tumour growth; for example, the
development of trichofolliculomas and pilomatricomas (Gat et al.,
1998), illustrating the need for precise regulation of the Wnt/β-
catenin pathway in the HF. Wnt/PCP signalling has also been
shown to play a role in HF development by coordinating the
asymmetric morphogenesis of the developing HFs (Devenport and
Fuchs, 2008).
Mutations in the PORCN gene, which encodes the Porcupine
homologue protein involved in secretion and processing of Wnt,
are associated with focal dermal hyperplasia (FDH). In mice,
inactivation of Porcn in the ectoderm resulted in alopecia, thin
skin and tooth anomalies (Barrott et al., 2011; Liu et al., 2012),
while mutations in the Wnt effectors, Tcf3 and Tcf4, resulted in a
thinner epidermis (Nguyen et al., 2009). In the IFE there are no
Lgr5þ cells, but the recent identiﬁcation of Wnt signalling-
dependant epidermal stem cells in the basal layer of the epidermis
further underscores the key role of Wnt signalling for IFE integrity
(Choi et al., 2013; Lim et al., 2013). Other attempts at altering Wnt/
PCP signalling, for example, by knocking out the Frizzled (Fz) 2 and
7 receptors required for Wnt and PCP signalling, resulted in
truncation and kinking of the mouse tail (Yu et al., 2012). In
addition, the double knockout of Fz7 and Wnt5a, a ligand inducing
PCP signalling, caused further shortening of the tail and early
lethality. Knockout of Edaradd, the transducer of Edar signalling,
required for normal skin development, also resulted in a kink tail
phenotype (Heath et al., 2009). Furthermore, interplay and inter-
dependence has been demonstrated between Wnt/β-catenin and
Edar/NF-κB signalling pathways in primary HF placode formation
(Zhang et al., 2009).
Lgr5 null mice showed ankyloglossia and 100% neonatal leth-
ality, demonstrating the importance of Lgr5 (Morita et al., 2004);
however, the exact molecular mechanism(s) underlying this phe-
notype is unknown. Although Lgr5 is not required for Wnt sig-
nalling, these results support the hypothesis that the regulatory
role played by Lgr5 in the Wnt/PCP signalling pathway is indis-
pensable for the integrity of key developmental processes
dependant on Wnt/PCP signalling.
To elucidate further the effects of Lgr5 overexpression on
developmental processes and consequences for Wnt/PCP signalling,
we set out to generate a conditional and inducible transgenic mouse
model. In this model LGR5 is expressed under the control of a tet-
racycline inducible promoter. Induction of LGR5 expression during
embryogenesis and early development in keratin 5-expressing cells
resulted in several phenotypic changes, including lower body mass,
sparse fur coat and kink tail. Hyperproliferation of the IFE and
accelerated maturation of the sebocytes was also evident. The sumof these ﬁndings supports a sensitivity to misregulated LGR5 sig-
nalling during development.Methods
Transgenic mice and genotyping
A tetracycline-regulated LGR5 expression construct was gener-
ated by subcloning PCR-ampliﬁed cDNA encoding the open read-
ing frame of human LGR5 into the pTRE-Tight-Linker12 expression
vector. This is a modiﬁed version of the pTRE-Tight vector (Clon-
tech), which includes two additional restriction enzyme sites
(NruI) at the 3′ and 5′ ends of the multiple cloning site. The con-
struct was veriﬁed by sequencing and doxycycline-induced
expression was conﬁrmed in a human keratinocyte cell line stably
transfected with the reverse tetracycline transactivator (HaCat-
rtTA) (Regl et al., 2002). Doxycycline-induced expression of LGR5
was conﬁrmed by PCR using cDNA, generated from mRNA isolated
from doxycycline-treated cells, as the template. The pTRE-Tight-
Linker12-LGR5 vector construct was cleaved with the NruI
restriction enzyme and injected into pronuclei of fertilised mouse
oocytes of the FVB/N strain at the Karolinska Center for Transgene
Technologies (KCTT).
The putative founders obtained were genotyped by PCR with
primers speciﬁc for the human LGR5 sequence. Five founders were
crossed with wild type (WT) FVB/N mice to establish the F1 gen-
eration. Expression levels of induced human LGR5 mRNA in the
founder strains were determined by crossing TRELGR5 mice with
K5tTA mice, which carry the tetracycline transactivator (tTA) gene
downstream of the skin-speciﬁc keratin 5 (K5) promoter (Dia-
mond et al., 2000). During embryogenesis and nursing of the
offspring, the breeding dams were either treated with doxycycline
to prevent induction of LGR5 expression, or doxycycline was
withheld to allow LGR5 expression. Doxycycline was administered
in the drinking water (2 g/l doxycycline in 5% sucrose). Upon
weaning at postnatal day 21 (P21), a dorsal skin biopsy was taken
from the offspring bred and nursed in the presence of doxycycline.
Doxycycline was then withheld from the mice for 6 weeks before a
new dorsal skin biopsy was taken from the same region. LGR5
mRNA levels in the skin biopsies were determined by reverse
transcriptase quantitative (RT-q) PCR using primers speciﬁc for
human LGR5. The interfollicular distances in the skin biopsies were
determined by measuring the distance between pilosebaceous
units on calibrated images. The statistical signiﬁcance of any dif-
ferences between the LGR5-expressing and control groups was
calculated using the Student's t-test (n¼12 LGR5 expressing and
n¼17 control mice). Expression of LGR5 in the mammary gland
was obtained by crossing TRELGR5 mice with MMTVrtTA mice,
which carry the reverse tetracycline transactivator (rtTA) gene
downstream of the mouse mammary tumour virus promoter.
Expression of LGR5 was induced by administration of doxycycline
in the drinking water (2 g/l doxycycline in 5% sucrose) from the
time of weaning (P21) until sacriﬁce. All transgenic mice were
generated and maintained within a speciﬁc pathogen free (SPF)
barrier facility according to local and national regulations, and the
Stockholm South Animal Ethics Committee approved all experi-
ments in advance of their implementation.
Immunohistochemistry
Mouse tissue was ﬁxed overnight in 4% paraformaldehyde
(PFA) or Fekete's ﬁxative, routinely processed and parafﬁn
embedded. The parafﬁn-embedded tissue was sectioned at 3 μm.
The tissue sections were deparafﬁnised in xylene and re-hydrated
through a graded series of ethanol. Heat-induced antigen retrieval
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or Diva decloacer (DV2004MX, Biocare Medical), either by incu-
bating the slides in a steam cooker or using the Retriever 2100
pressure cooker (Electron Microscopy Science). Subsequently, the
slides were rinsed in phosphate buffered saline (PBS) and incu-
bated in 2.5% hydrogen peroxide in methanol to block endogenous
peroxidase activity. The sections were washed in PBS and blocked
in 5% serum corresponding to the host organism of the applied
secondary antibody. The tissue sections were incubated with the
primary antibody (rabbit polyclonal anti-Ki67, Novocastra NCL-
Ki67p; rabbit monoclonal anti-β-catenin, Abcam ab32572; rabbit
polyclonal anti-keratin 5, Covance PRB-160P; rabbit polyclonal
anti-keratin 6, Covance PRB-169P; rabbit polyclonal anti-keratin
10, Covance PRB-159P; rabbit polyclonal anti-keratin 14, Covance
PRB-155P; goat polyclonal anti-Scd1, Santa Cruz Biotechnology ac-
14719; rabbit polyclonal anti-phospho-Smad1/5/9, Cell Signalling
#9511) in 0.1% bovine serum albumin (BSA) for 1 h at room tem-
perature or overnight at 4 °C. Subsequently, the sections were
washed in PBS and incubated with biotinylated secondary anti-
bodies in PBS supplemented with 5% serum corresponding to the
host organism of the secondary antibody. The slides were washed
in PBS, incubated with streptavidin peroxidase for 10 min and
washed again in PBS before visualising the samples using the 3,3′-
Diaminobenzidine (DAB) substrate. The sections were counter-
stained with hematoxylin. For quantitative analyses of the
immunohistochemistry (IHC)-stained tissue sections, the numbers
of positive cells were counted in 5–10 ﬁelds at 40 magniﬁcation
under a light microscope.
PCR and RT-qPCR
All experimental mice were ear marked and genomic DNA
(gDNA) extracted from the ear punches was used for genotyping
by qualitative PCR. The genotyping primer sequences were as
follows: human LGR5-FW (5′-TTC AGG CTC AAG ATG AAC GT-3′)
and human LGR5-Rev (5′-CTG TTG AAG TCA CCA AAG CA-3′); tTA-
FW (5′-CTC GCC CAG AAG CTA GGT GT-3′) and tTA-Rev (5′-CCA
TCG CGA TGA CTT AGT AA-3′); MMTVrtTA-FW (5′-ATC CGC ACC
CTT GAT GAC TCC G-3′) and MMTVrtTA-Rev (5′-GGC TAT CAA CCA
ACA CAC TGC CAC-3′). The same human LGR5 primer pair was used
for reverse transcriptase quantitative (RT-q) PCR to determine the
LGR5 mRNA levels in transgenic mice skin samples. The expression
levels of genes of interest were determined by RT-qPCR using
cDNA, constructed from mRNA isolated from dorsal skin biopsies,
as the templates. The sequences of the gene-speciﬁc RT-qPCR
primers are summarized in Table 1. Two normalisation genes,
glyceraldehyde-3-phosphate dehydrogenase (Gapd) and β-actin
(Actb) were used to determine relative mRNA levels. The primer
pairs for the normalisation genes were obtained from Applied
Biosystems/Life technologies. RNA was isolated from tissueTable 1
Primer sequences.
Primer name Sequence
Wnt5a-fw AAT CCA CGC TAA GGG TTC CT
Wnt5a-rev CCG CGC TAT CAT ACT TCT CC
Rspo1-fw ATG CAT CAA ATG CAA GAT CGA G
Rspo1-rev GGA CCA CTC GCT CAT TTC AC
Rspo2-fw ATG TGT AGA AGG TTG TGA AGT TGG
Rspo2-rev CTT TGG TGT TCT CTT TCC TCC T
Rspo3-fw TGT GTC AGT ATT GTA CAC TGT GAG
Rspo3-rev ATA CAA GTT CTT GTC TCG CTG G
Rspo4-fw AAC AGG TGC AAG AAA TGT GGG
Rspo4-rev TAC TCT GGT GGG TCA AGG TG
E-cadherin-fw GGA CGT CCA TGT GTG TGA CT
E-cadherin-rev GAT CAG AAT CAG CAG GGC GAsamples harvested from WT or double transgenic mice, using the
RNeasy kit (Qiagen) and cDNA was generated using oligo dT pri-
mers and SuperScript reverse transcriptase (Invitrogen) according
to the manufacturers' protocols.
Skeletal staining
To visualize cartilage and bone in embryonic skeletons, cleared
skeletons were stained with Alcian Blue 8X (Sigma) and Alizarin
Red S (Sigma), using standard protocols (Hogan et al., 1994).
Brieﬂy, embryonic day 18.5 (E18.5) embryos were skinned, evis-
cerated and ﬁxed in 95% ethanol for 5 to 6 days. The skeletons
were then stained with 0.015% Alcian Blue 8X dissolved in 20%
glacial acetic acid/80% ethanol for 2 days. After washing the
embryos with 95% ethanol for 2 days, they were cleared for 3 h
with 1% KOH and then counterstained with 0.005% Alizarin Red S
in 2% KOH for 2 h. After clearing with 2% KOH for 1 day, the ske-
letons were immersed in decreasing ratios of 2% KOH to glycerol
and ﬁnally stored in a 20% KOH:80% glycerol solution until
photographed.
Skin permeability assay
To determine skin permeability status of the double transgenic
mice, embryos were stained with 5-bromo-4-chloro-3-indolyl-β-
D-galactopyranoside (X-gal) according to the previously described
protocol (Hardman et al., 1998). In brief, embryos of the desired
age (E17.5) were surgically removed from the dam, rinsed in PBS
and subsequently immersed in X-gal reaction mix at pH4.5
(100 mM NaPO4 [Sodiumphosphate], 1.3 mM MgCl2, 3 mM K3Fe
(CN)6, 3 mM K4Fe(CN)6 and 1 mg/ml X-gal) and incubated over-
night at 30 °C. The stained embryos were washed and maintained
in PBS and photographed using a stereomicroscope (Zeiss SteREO
Discovery.V20). The pictures were edited with Adobe Photoshop to
include the whole embryo in one picture.
Transepidermal water loss (TEWL) measurements
Dorsal skin of control and K5tTA;TRELGR5 LGR5 expressing
mice were shaved (approximately 1.51.5 cm2) and TEWL mea-
sured with a Tewameter TM300 (Courage and Khazaka electronic
GmbH). The TM-300 consists of individual humidity and tem-
perature sensors in an open chamber for measurements of the
water evaporation at the skin surface. Each animal was measured
at least once at four different days. The measurements were con-
ducted according to the manufacturer's instructions.
Micro-computed tomography (μCT) scanning
Skulls from WT and double transgenic (K5tTA;TRELGR5) mice
were scanned with a μCT scanner (Quantum FX μCT Pre-Clinical In
Vivo System, PerkinElmer). Cephalometric measurements between
anatomical reference landmarks were used to evaluate the skulls as
outlined by de Carlos et al. (2011) (See Supplementary Fig. 1).
In situ RNA hybridisation
In situ RNA hybridisation was performed using RNAscope
technology (Advanced Cell Diagnostics) according to the manu-
facturer's instructions for chromogenic singleplex and duplex
hybridization. In brief, formalin-ﬁxed, parafﬁn-embedded mouse
skin was cut into 4.5 μm sections and mounted on SuperFrost Plus
slides. The slides were deparafﬁnised and subsequently incubated
with probes speciﬁc for human LGR5, mouse Lgr5 or mouse Axin2
mRNA. The tissue samples were counterstained with hematoxylin
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and documentation.Results
Generating the TRELGR5 transgenic mouse
To explore the functional role of LGR5 expression in tissue
morphogenesis, we generated a conditional transgenic mouse line
harbouring an inducible TRELGR5 construct. A cDNA encoding the
human LGR5 open reading frame sequence was cloned into the
BamHI and NotI restriction enzymes sites of the pTRE-Tight-Lin-
ker12 vector (Fig. 1A).
Five potential founder mice were generated after pronuclear
injections of the NruI restriction enzyme-digested pTRE-Tight-
Linker12-LGR5 construct. Four of these gave ﬁrst generation (F1)
offspring with the desired genotype and founder lines were
established. To induce expression of LGR5 in the skin, TRELGR5
mice were crossed with K5tTA transgenic mice expressing the
tetracycline responsive transactivator in K5þ cells. Breeding and
lactating dams were kept on doxycycline to prevent expression of
LGR5 during embryogenesis and lactation in double transgenic
offspring. The offspring were taken off doxycycline at weaning
(P21) to induce expression of transgenic LGR5. Dorsal skin biopsiesFig. 1. TRELGR5 DNA construct and induced LGR5 expression. (A) Full length cDNA
encoding human LGR5was cloned into the BamHI and NotI restriction enzyme sites
of a modiﬁed version of the pTRE-Tight expression vector harbouring additional
NruI restriction enzyme sites on both sides of the TRE-CMV multiple cloning site.
(B) Breeding and lactating dams were treated with doxycycline to suppress
expression of LGR5 in double transgenic embryos and newborns. Upon weaning at
the age of 3 weeks (P21), exposure to doxycycline was stopped to induce LGR5
expression. A skin biopsy was taken at P21 and again at P63 after 6 weeks of
induced LGR5 expression. (C) RT-qPCR analyses of skin biopsies taken at P63 con-
ﬁrmed the induction of LGR5 expression in bigenic mice. Making either one of the
transgenic alleles homozygous caused a further increase in the LGR5 mRNA
expression (nLGR5¼9, ntriple_transgenic¼14, *p-valueo0.05). Bars represent average
expression levels relative to two normalisation genes (Gapd and Actb), SEM is
indicated.were taken at P21 and again at P63 (9 weeks), after 6 weeks of
induced LGR5 expression (Fig. 1B). RT-qPCR was used to determine
LGR5 mRNA expression levels in the skin biopsies. There was no
detectable expression of human LGR5 mRNA at the time of
weaning (P21), conﬁrming that exposure to doxycycline effectively
suppressed LGR5 expression. After 6 weeks of induced LGR5
expression, comparable LGR5 mRNA levels were present in double
transgenic mice from all TRELGR5 lines. Mice, homozygous for one
of the transgenic alleles (either K5tTA or TRELGR5) and hetero-
zygous for the other transgenic allele, showed a further increase in
LGR5 mRNA levels (Fig. 1C). There was no expression of human
LGR5 mRNA in TRELGR5 single transgenic mice.
To verify that expression of human LGR5 mRNA could be
induced in various tissues, depending on the choice of transacti-
vator, LGR5 mRNA expression was conﬁrmed in mammary gland
tissue in a double transgenic mouse, MMTVrtTA;TRELGR5 (Sup-
plementary Fig. 1A). Expression was continuously induced from
P21 until sacriﬁce and tissue collection at P72. Hematoxylin and
eosin (H&E) staining of formalin ﬁxed parafﬁn embedded (FFPE)
tissue showed no phenotypic changes to the mammary gland
epithelial tissue at this age (Supplementary Fig. 1B).
Phenotypic changes in conditional double transgenic K5tTA;TRELGR5
mice with induced expression of LGR5 during development
To address the effect of induced LGR5 expression in K5þ ker-
atinocytes during embryogenesis, K5tTA;TRELGR5 mice were bred
without exposing the pregnant females and lactating dams to
doxycycline. The litters were examined at P11. The double trans-
genic mice continuously expressed LGR5 and were easily identi-
ﬁable due to distinct phenotypic changes, which were present
throughout the lifespan of these mice. Compared to WT mice, the
fur in the double transgenic animals appeared less dense on the
ventral and dorsal sides and in particular on the head and behind
the ears (Fig. 2A–D). The double transgenic mice appeared smaller
and had a signiﬁcantly lower body mass compared to control
offspring at the ﬁrst examination prior to weaning at P21 (Fig. 2E).
Multivariate regression analyses showed that adult double trans-
genic mice also had a signiﬁcantly (p-valueo0.05) lower body
mass than the WT and single transgenic animals, independent of
age and gender (Supplementary Fig. 2). The reduced body mass
might indicate defects in the skin barrier. Thus, we asked whether
the skin permeability of the LGR5 expressing mice was altered. The
skin barrier forms at E16 and is fully developed at E18.5 in WT
animals, gradually developing from the dorsal to the ventral side
of the embryo (Hardman et al., 1998; Turksen and Troy, 2002).
Double transgenic and WT embryos (E17.5) were stained in X-gal
solution and, as expected, the skin barrier had started to form from
the dorsal side in WT embryos and the same pattern was observed
in double transgenic embryos (Fig. 2F and G). In adult mice, the
status of the skin barrier might be determined by measuring the
transepidermal water loss (TEWL). In female adults there were no
statistically signiﬁcant (p40.05) difference in TEWL measure-
ments between LGR5 (2.0 mg/m2/h) and non-LGR5 (1.0 mg/m2/h)
expressing mice. There was a statistically signiﬁcant (po0.05)
difference between male LGR5 (2.0 mg/m2/h) and non-LGR5
(0.6 mg/m2/h) expressing mice. Collectively, these analyses
showed that the skin barrier develops normally in embryonic skin,
but the continued development of the barrier in male postnatal
LGR5 expressing mice may be disturbed. In addition to inducing
expression of the TRE regulated transgenes in skin, the K5tTA
mouse is known to induce expression in other tissues, including
forestomach, tongue and oesophagus (Diamond et al., 2000).
Expression of transgenic human LGR5 in these tissues might con-
tribute to the observed reduce body masse.
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resulted in a kink tail phenotype with 100% penetrance. This
phenotype was apparent from the ﬁrst examination of the pups at
P11 and throughout the entire lifespan of the mouse (Fig. 3A).
Micro-CT scans of the kinked tails showed malformations of caudal
vertebra in the kink area (Fig. 3B). To determine whether the kink
tail phenotype was caused by deformation of the skeleton during
development, embryo skeletons were stained with Alcian blue and
Alizarin Red S to visualise bone and cartilage. At E18.5, there were
no signs of skeletal malformations in embryos with induced LGR5
expression during embryogenesis and the embryonic skeleton was
comparable to WT skeletons (Fig. 3C and D). Upon macroscopic
examination of postnatal mice, the skulls of the LGR5 expressing
mice appeared to be narrower and longer than the skulls of the
non-LGR5 expressing littermates. To investigate a potential dif-
ference in cranium size, μCT scans were performed to determine if
the craniums of the double transgenic mice were smaller than
control craniums (Fig. 3E) (nwt¼5, nLGR5¼10; average agewt¼69
weeks, average ageLGR5¼70 weeks). The anatomical reference
landmarks used for the 3D-μCT scan measurements are outlined in
Supplementary Fig. 3 and Table 2. These scans revealed no sig-
niﬁcant differences in cranium size between the control and
double transgenic mice (Fig. 3F).
The sparse fur, kink tail and low body mass phenotypes
induced by LGR5 expression during embryogenesis and early
development were present through the life span of the double
transgenic mice as long as LGR5 expression was maintained. In
some cases the phenotypic changes became more pronounced
during old age. However, some older mice also started scratching,
which might have contributed to the more severe skin hyperplasia,
ulcerative changes and keratinisation observed in some of these
animals.
Taken together, these data show that expression of LGR5 in
K5þ cells during development resulted in macroscopically
detectable phenotypic changes, including sparse fur, kink tail and
lower body mass.
K5tTA;TRELGR5 mice show phenotypic changes in the sebaceous
glands and interfollicular epidermis
Dorsal skin biopsies from double transgenic mice (K5tTA;
TRELGR5), with LGR5 expression induced during development,
were harvested for histological analyses. At 5.5 weeks, early ana-
gen HFs from these LGR5-expressing mice showed increased
presecretory degradation of sebocytes compared to WT mice
(Fig. 4A and B). At 81 weeks, WT animals showed normal anagen
HFs. In contrast, LGR5-expressing mice of the same age showed a
further increase in sebocyte degradation and an irregular HF
outline with hyperplasia of the basal keratinocyte layers sur-
rounding the bulge and infundibular regions, as well as IFE
hyperplasia (Fig. 4C and D). The observed hyperplasia varied and
was observed as long as the expression of LGR5 was induced (age
ranging from 3.4 to 95.6 weeks). It appeared multifocal and in
some of the HFs the hyperplasia was centred around the follicular
infundibula. A marked increase in sebocyte degeneration andFig. 2. Phenotypic changes in K5tTA;TRELGR5 bigenic mice with induced expres-
sion of LGR5 during embryogenesis and throughout the entire life span. Compared
to the WT mice (A and C) the double transgenic K5tTA;TRELGR5 mice appeared
smaller (B and D). The fur was less dense in LGR5-expressing mice (B and D)
compared to WT mice (A and C). (E) The double transgenic mice showed sig-
niﬁcantly lower body mass compared to WT mice. Body mass was measured before
weaning, at P14–20 (nWT¼nLGR5¼7, 4 mice at 20 days and 3 mice at 14 days in each
group; p-valueo0.01). (F and G) Control (F) and LGR5 expressing (G) embryos
(E17.5) were stained in a X-gal solution for skin permeability analyses. All biallelic
mice shown in this ﬁgure are heterozygous.irregular pilosebaceous proﬁles was observed in 27 out of 30
LGR5-expressing mice analysed, and minimal degeneration was
Fig. 3. Skeletal analyses of embryos and adult mice with induced LGR5 expression. (A) The double transgenic mice showed a kink tail phenotype, with 100% penetrance.
(B) 3D-μCT scans of the kinked tails showed that the tail vertebrae on both sides of the kink were deformed. (C and D) Embryo (E18.5) skeleton staining revealed no
differences between WT and LGR5-expressing embryos. (E) 3D-μCT analyses of skull skeletons revealed no size differences between WT (upper panels) and LGR5-expressing
(lower panels) mice. (F) The 3D-μCT scan analyses revealed no signiﬁcant changes in skull size resulting from induced LGR5 expression during development
(nLGR5¼10, nWT¼5). All biallelic mice shown in this ﬁgure are heterozygous.
J.H. Norum et al. / Developmental Biology 404 (2015) 35–4840only observed in 10 out of 32 non-LGR5-expressing mice. Reduced
sebum production was observed in the asebia mutant mice, which
are models for scarring alopecia and harbour a mutation in the
gene encoding the enzyme stearoyl-CoA desaturase 1 (Scd1)
(Sundberg et al., 2000; Zheng et al., 1999). We stained FFPE skin
tissue sections from LGR5 and non-LGR5 expressing mice with an
antibody against Scd1. The sebocytes in the sebaceous gland of the
non-LGR5 expressing mice displayed continuous intensitygradients for Scd1 (Fig. 4E). The sebocytes in the LGR5 expressing
skin also showed an intensity gradient when stained with an anti-
Scd1 antibody, but the gradient was not as uniform as in non-LGR5
expressing skin (Fig. 4F).
The thin fur phenotype could depend on an increased inter-
follicular distance. The number of HFs in E18.5 dorsal skin was
found to be signiﬁcantly lower in double transgenic compared to
control mice (on average 8.7 vs 12.6 HFs per 20 ﬁeld, p-
Table 2
Anatomical reference landmarks for 3D-μCT scan measurements.
Measurement Description
A Cranial length: measured between the internasal (top of the nose) and the occipital (the most distal point of the occipital bone) points.
B Inter-nasal distance: measured between both nasal lateral points.
C Inter-orbitary length: measured between right and left infraorbital foramina.
D Inter-zygomatic distance: measured between both zygion points.
E Bi-temporal distance: measured in the more distant point of the jugal process off squamosal with respect to the sagittal plane.
F Palatine length: measured between the posterior nasal spine and the inter-dental point.
G Sagittal cranial distance: measured between the occipital and the naso-maxillary point.
H Posterior cranial height: measured between the tympanic and the parietal point.
I Anterior cranial height: measured between the upper incisor and the prostion points.
J Upper incisor height: measured between the upper incisor–alveolar bone and upper incisor edge.
K Effective mandible length: measured between the lower alveolar incisor (infradentale) and the condilyon points.
L Mandible plain: measured between the gonion and the lower incisor–alveolar bone.
M Mandible axis: measured between the antegonium and menton points.
N Inferior incisor height: measured between the lower incisor–alveolar bone and the lower edge.
O Anterior mandible height: measured between the menton and the mandibular alveolar (or diastema) points.
Q Posterior mandible height: measured between the gonion and condilion points.
P Condiloid axis (length of the ascending ramus): measured between the condilion and antegonion points.
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Fig. 4. HFs, IFE and SG from LGR5-overexpressing mice compared to WT at different ages. (A and B) Comparison of early anagen follicle and IFE in biopsies of WT mouse (A) and
LGR5-overexpressing mouse (B) shows increased pre-secretory degeneration of sebocytes in the LGR5 animal at 5.5 weeks post-partum. (C and D) At 81 days post-partum, the
skin of WT mouse (C) shows normal early anagen follicles whereas respective similar stage follicles in LGR5 mouse (D) reveal further sebocyte degeneration, irregular follicular
outline and hyperplasia of the basal keratinocyte layers surrounding the bulge and infundibular regions of the HF, as well as IFE hyperplasia. Scale bars represent 25 mm. (E and
F) Immunohistochemical staining for Scd1 in adult WT (E) and LGR5 expressing (F) skin. All biallelic mice shown in this ﬁgure are heterozygous.
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Fig. 5. Expression of endogenous and human LGR5 mRNA in embryonic and adult skin. Panels A–A3: WT and B–B3: K5tTA;TRELGR5 LGR5 expressing skin. (A and B) H&E-
stained embryonic (E18.5) skin with early HFs from WT (A) and double transgenic mice (B). (A1) RNA in situ hybridisation of WT embryonic (E18.5) skin sections with a
probe for mouse Lgr5 mRNA (red dots, indicated with arrows). (B1) Duplex RNA in situ hybridisation of embryonic LGR5 expressing skin with probes for endogenous Lgr5
(red dots, indicated with arrows) and human LGR5 (blue dots) mRNA. (A2) The RNA in situ hybridisation probe for human LGR5 did not show unspeciﬁc hybridisation to WT
embryonic (E18.5) skin. (B2) Singleplex RNA in situ hybridisation with a probe for human LGR5 mRNA in embryonic (E18.5) skin from double transgenic embryos obtained
from breeding dams treated with doxycycline. (A3) RNA in situ hybridisation of WT adult skin with a probe for mouse Lgr5 mRNA (red dots, indicated with arrows). (B3)
Duplex RNA in situ hybridisation of adult LGR5 expressing skin with probes for endogenous Lgr5 (red dots, indicated with arrows) and human LGR5 (blue dots) mRNA. (C and
D) Singleplex RNA in situ hybridisation with a probe for human LGR5 mRNA in adult skin (age 47 weeks [D] and 34.4 weeks [E]). Note the pronounced expression of LGR5
mRNA in the SGs and HFs (indicated with arrows). All biallelic mice shown in this ﬁgure are heterozygous.
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J.H. Norum et al. / Developmental Biology 404 (2015) 35–48 43valueo0.05) (Fig. 5A and B). Analyses of H&E-stained adult dorsal
skin sections showed a non-signiﬁcant trend towards an increased
interfollicular distance in the double transgenic mice compared to
WT.
We addressed the relative expression levels of endogenous and
transgenic Lgr5 by duplex RNA in situ hybridisation. This method
allows direct examination of mRNA levels in individual cells and
enables identiﬁcation of potential changes in the cell population
(s) expressing the various mRNAs. In developing skin, endogenous
Lgr5 mRNA was expressed in the lower half of the early HFs
(Fig. 5A1). The expression of transgenic human LGR5 mRNA in
embryonic skin was not limited to the HFs and was also apparent
in the IFE (Fig. 5B1 and B2). There was no expression of human
LGR5 mRNA in the control embryonic skin (Fig. 5A2). In adult skin,
endogenous Lgr5 mRNA expression was similarly located to the
lower part of the HFs, e.g. in telogen expression was limited to the
secondary germ (Fig. 5A3). Induced expression of human LGR5 did
not alter the expression pattern of endogenous Lgr5, but human
LGR5 was also in adult skin detected throughout the entire HF and
IFE (Fig. 5B3, C and D). In adult double transgenic mice, expression
of LGR5 mRNA was strong in both the basal and suprabasal cells in
the hyperplastic areas as well as in the sebaceous glands (Fig. 5C).
LGR5 expression remained strong in the HFs in the skin areas of
the induced double transgenic mice without IFE hyperplasia, but
only few cells expressed LGR5 mRNA in these IFE areas (Fig. 5D).
The underlying mechanisms for the apparently low expression of
human LGR5 mRNA in these non-hyperplastic areas is at present
not known.
Recently, bone morphogenetic protein (Bmp) was assigned a
role in regulating Lgr5 levels in intestinal adenomas (Whissell
et al., 2014). In addition, Bmp signalling is a known regulator of HF
stem cell homoeostasis and differentiation via the effectors
pSmad1, 5, and 8 (Kandyba et al., 2014). Embryonic and adult skin
tissue sections were stained with an antibody against pSmad1/5/9
(Smad9 is an alternative name for Smad8) and the results showed
that the expression pattern of pSmad1/5/9 did not differ between
LGR5 and non-LGR5 expressing mice (Fig. 6A–D).
To determine whether the hyperplastic areas in the IFE con-
tained actively proliferating cells, skin tissue sections were stained
with an antibody against the proliferation marker Ki67 and the
number of positive cells in the IFE was counted. The median
number of Ki67þ cells in adult skin was 3.0 for WT and 4.0 in the
LGR5-expressing group, with a signiﬁcant difference between theEmbryonic
pSmad1-5-8
Wild type K5tTA;TRELGR
Ki67
Fig. 6. pSmad1/5/8 and Ki67 expression in embryonic and adult WT and K5tTA;TRELG
against pSmad1/5/8 in embryonic (A and B) and adult (C and D) skin sections from W
nohistochemistry staining with an antibody recognising Ki67 protein in skin sections fro
and H) mice, with induced LGR5 expression (F and H). All biallelic mice shown in this ﬁdistributions of the 2 groups (Wilcoxon–Mann–Whitney test
nwt¼nLGR5¼15 animals, po0.01) (Supplementary Fig. 4). The
Ki67þ cells were found in the HFs and IFE (Fig. 6E–H). In the
hyperplastic IFE areas, Ki67þ cells were located mainly in the
basal cell layer and only sporadically positive cells were detected
in the suprabasal layers. There were no signs of neoplastic lesions.
Taken together, these data show that induced LGR5 expression
in K5þ skin cells during embryogenesis, and indeed, the entire life
span of an adult mouse, resulted in the degradation of sebocytes
and abnormal sebaceous glands, detectable at the microscopic
level, in addition to a hyperplastic IFE with actively proliferating
cells residing in the HFs and in the basal cell layer of the IFE.
Furthermore, the number of HFs in the double transgenic LGR5
mRNA-expressing embryonic skin was signiﬁcantly lower than in
control (WT) embryonic skin.
LGR5 expression in K5þ cells induces appearance of K6 expressing
cells in the IFE
Keratins exhibit characteristic expression patterns in skin, are
the major structural components of the keratinocytes and are
essential for establishing the physical strength of the keratinocytes
and for prevention of skin rupture. Transgenic expression of
human LGR5 in K5þ cells may interfere with skin differentiation
and the characteristic expression patterns. To address this ques-
tion we performed immunohistological analyses with antibodies
targeting different keratins in embryonic and adult skin. Keratin
5 and 14 are predominantly expressed in the basal cell layer of the
skin in both LGR5 and non-LGR5 expressing embryonic and adult
skin (Fig. 7). In skin biopsies from LGR5-expressing mice, immu-
nohistochemical analyses with an antibody directed against ker-
atin 6 (K6) stained the inner root sheath (IRS) (Fig. 7). In addition,
several K6þ cells were detected in the IFE of LGR5-expressing
mice (Fig. 7). There were no K6þ cells observed in the IFE of the
control mice (Fig. 7). In normal healthy skin keratin 10 is expressed
in the suprabasal cell layer. A similar pattern was observed in
embryonic and adult LGR5 and non-LGR5 expressing skin (Fig. 7).
Discontinued expression of human LGR5 results in reversion to a
normal skin phenotype
Expression of the tetracycline regulated LGR5 transgene is
efﬁciently suppressed by doxycycline administration. Mice bred inAdult
5 K5tTA;TRELGR5Wild type
R5 LGR5 expressing skin. (A–C) Immunohistochemistry staining with an antibody
T (A and C) and LGR5 expressing double transgenic (B and D) mice. (E–H) Immu-
m WT (E and G) and double transgenic (F and H) embryonic (E and F) and adult (G
gure are heterozygous.
Embryonic
K14
K5tTA;TRELGR5
K5
Adult
K6
K10
K5tTA;TRELGR5Wild type Wild type
Fig. 7. Expression of keratins in developing and adult skin. Immunohistochemical staining of embryonic (E18.5) (A, B, E, F, I, J, M and N) and adult (C, D, G, H, K, L, O, and P)
skin from WT (A, E, I, M, C, G, K, and O) and LGR5 expressing (B, F, J, N, D, H, L and P) mice with antibodies against K5 (A–D), K14 (E–H), K6 (I–L) and K10 (M–P). All images
were taken with a 40x objective, except (L) which was taken with a 20x objective and the insets with a 40x objective. All biallelic mice shown in this ﬁgure are heterozygous.
J.H. Norum et al. / Developmental Biology 404 (2015) 35–4844the presence of doxycycline to prevent LGR5 expression until the
induction of LGR5 at P21 (4100 K5tTA;TRELGR5 mice), main-
tained a normal skin phenotype throughout their entire life span
and did not develop tail kinks. These results support an association
between the phenotypic changes associated with LGR5 expression
during embryogenesis and early development. Stopping LGR5
expression at P21 by exposing the mice to doxycycline, did not
reverse the kink tail phenotype induced during the ﬁrst 21 days of
postnatal development. However, macroscopic and microscopic
examinations revealed that the sparse fur phenotype reverted to
normal when LGR5 expression was arrested at P21. In addition, the
sebaceous glands gained a normal morphology when analysed at
the age of 16 weeks (Fig. 8A). The expression pattern of Scd1 in the
sebaceous glands of the mice no longer expressing human LGR5
resembled the continuous gradient observed in non-LGR5
expressing skin (Fig. 8B). K5 expressing cells were located in the
basal cell layers (Fig. 8C). Immunohistochemical analyses revealed
that the expression pattern of K6 in skin tissue sections from mice
expressing human LGR5 during embryogenesis and until P21 was
similar to the expression pattern observed in non-LGR5 expressing
skin with no K6 positive cells in the IFE (Fig. 8D).
Expression of LGR5 in K5þ cells does not activate the Wnt/β-catenin
pathway but increases expression of the non-canonical ligand Wnt5a
The LGR5 receptor binds Rspo1–4 and enhances Wnt-induced
signalling in vitro (Carmon et al., 2011; de Lau et al., 2011). To
investigate whether increased LGR5 expression in the K5þkeratinocytes promoted Wnt signalling, dorsal skin sections were
stained with an antibody against β-catenin. IHC staining of skin
samples from mice (ranging from 5.1 to 72.9 weeks old) showed
no difference in the expression pattern or localisation of β-catenin
in LGR5-expressing skin compared to controls, suggesting that
canonical Wnt signalling was not markedly affected in adult LGR5-
expressing skin (data not shown). We performed RNA in situ
duplex hybridisation to determine the expression levels and pat-
terns of Axin2 and human LGR5 mRNA in embryonic and adult
control and LGR5 expressing skin samples. Axin2 expression was,
as expected, detected in HFs and in some few cells of the IFE
(Fig. 9A and B). There was no apparent increase in Axin2 mRNA
levels neither in general nor in cells expressing human LGR5
mRNA. In support of the RNA in situ hybridisation data, RT-qPCR
analyses of whole skin tissue samples revealed that induced
embryonic LGR5 expression did not alter the expression of the
canonical Wnt signalling target gene, Axin2, in adult mouse skin
(data not shown). The expression of the negatively regulated Wnt
target gene, E-cadherin, was signiﬁcantly increased in the adult
LGR5-expressing dorsal skin biopsies compared to non-LGR5
expressing skin biopsies (Fig. 9C).
The mRNA levels of Wnt5a, known to be involved in the reg-
ulation of hair shaft growth and an inducer of non-canonical Wnt
signalling (Xing et al., 2011), was determined by RT-qPCR. Wnt5a
expression levels in dorsal skin samples were increased sig-
niﬁcantly in double transgenic mice compared to control mice
(Fig. 9D). RT-qPCR was also used to determine the mRNA expres-
sion levels of the LGR5 receptor ligands, R-spondins 1–4. Rspo1, 2,
J.H. Norum et al. / Developmental Biology 404 (2015) 35–48 45and 4 mRNA levels showed a signiﬁcant increase in the doubleFig. 8. Resumption of normal sebaceous gland phenotype, K5 and K6 expression in
skin biopsies from mice with discontinued LGR5 expression. (A) Sebaceous glands
regained normal appearance when LGR5 expression, induced during embryogen-
esis and early development, was arrested at P21. (B–D) Immunohistochemical
staining with antibodies against Scd1 (B), K5 (C) and K6 (D) in adult skin sections
from mice with arrested LGR5 expression at P21. All skin biopsies were from mice
at the age of 16 weeks.transgenic mice compared to controls (Fig. 9E), but Rspo3 mRNA
levels did not. In HF morphogenesis, Wnt5a has been identiﬁed as
a Hedgehog signalling target (Reddy et al., 2001). The mRNA levels
of Gli1, the major effector of the Hh signalling pathway, were
determined by RT-qPCR and were shown to be up regulated in
LGR5-expressing skin (Fig. 9F).Discussion
Lgr5 is expressed on the surface of stem cells in several tissues
and Lgr5þ cells are known to play essential roles during devel-
opment (reviewed in Barker and Clevers, 2010). In addition, the
overexpression of LGR5 has been reported in cancers such as basal
cell carcinomas and hepatocellular carcinomas (McClanahan et al.,
2006; Tanese et al., 2008; Yamamoto et al., 2003). In colon cancer,
overexpression of LGR5 correlated with poor survival in patients
and in mouse models (Liu et al., 2014). Moreover, human kerati-
nocyte, HaCaT cells, overexpressing LGR5, became tumorigenic
when transplanted into immunodeﬁcient mice (Tanese et al.,
2008).
To clarify further the gain of function phenotype of LGR5,
TRELGR5, a conditional, tetracycline-inducible LGR5 transgenic
mouse line was generated for the current study. In this transgenic
line, LGR5 expression can be induced in different tissues
depending on the choice of promoter driving the expression of the
transactivator required for inducing LGR5 expression. In the cur-
rent study, we have shown that LGR5 expression can be induced in
skin or mammary gland, depending on the promoter choice.
The phenotypic changes observed in the double transgenic
mice (K5tTA;TRELGR5) were present as long as the LGR5 expres-
sion was maintained, but only when LGR5 expression was induced
during development. This observation supports an important role
for Lgr5 in mouse embryonic development and during the early
postnatal period (Morita et al., 2004). The K5 promoter we used to
drive the expression of the transactivator, has been shown to be
active from E9.5 in the dorsolateral region of the ectoderm over
the posterior somites, and by E16.5 the K5 promoter activity was
detected over the entire body (Byrne et al., 1994). The broad spatial
and temporal expression pattern of the K5 promoter-regulated
genes during development makes it difﬁcult to determine the
critical time point(s) for the induction of the LGR5-mediated
phenotypic changes. In adult mice the K5 promoter drives
expression of the transgene in the skin, forestomach, tongue, and
to a lower degree, in liver, kidney, heart and lung (Diamond et al.,
2000). The current study focuses on the induced expression of
LGR5 in the skin.
In the LGR5 expressing embryonic skin, we did not observe
changes in the K5 and K14 expression pattern or altered mor-
phology of developing HFs, as has previously been reported for
PCP signalling mutants (Devenport and Fuchs, 2008). These
observations suggest that induced LGR5 expression in K5þ cell
during embryogenesis is not sufﬁcient to alter morphology of
individual developing HFs either due to the cell population(s) that
are affected or the speciﬁc signalling properties of LGR5 receptor.
Arresting LGR5 expression at P21 reversed the sparse fur coat
phenotype observed in LGR5-expressing mice. At least two pos-
sible mechanisms might contribute to this reversion to an appar-
ently normal fur coat phenotype, either alone or in combination:
(1) de novo formation of HFs resulting from the loss of inhibitory
signals mediated via overexpression of the LGR5 receptor or
(2) recovered normal hair shaft growth and length as a result of re-
established normal skin homoeostasis. LGR5 expression also
resulted in the accelerated degeneration of sebocytes, which might
cause impaired function of the sebaceous glands and contribute to
the sparse fur coat phenotype (Miyazaki et al., 2001; Zheng et al.,
Fig. 9. Gene expression analysis. (A and B) Duplex in situ RNA hybridisation with probes against Axin2 (red dots, indicated with arrows) and human LGR5 (blue dots) mRNA
in embryonic (A) and adult (B, inset boxes show enlargements of areas indicated by arrows) skin sections. (C–F) Messenger RNA was isolated from dorsal skin biopsies from
LGR5-expressing and WT mice. The expression levels of E-cadherin (Cdh1) (C), Wnt5a (D), Rspo1–4 (E) and Gli1 (F) were determined by RT-qPCR. The expression levels are
relative to the expression levels of mRNA transcripts from two genes, Gapd and Actb. All genes tested (except for Rspo3) show a signiﬁcantly increased expression in samples
from LGR5-expressing mice compared to WT mice (nwt¼3, nLGR5¼6, average agewt¼63.2 and average ageLGR5¼52.4; p-valuer0.05). The bars represent average relative
mRNA expression. SEM is indicated. All biallelic mice analysed in this ﬁgure are heterozygous.
J.H. Norum et al. / Developmental Biology 404 (2015) 35–48461999). Prevention of LGR5 expression from P21 also restored the
normal sebaceous gland phenotype, suggesting that the sparse fur
coat might result from malfunctioning sebaceous glands. The
sebocytes express the stearoyl CoA desaturase (Scd1) enzyme that
is required for the normal function of the SG. The asebia 2J mouse
develops a progressive alopecia and the phenotypic changes have
been linked to the loss of expression of Scd1 (Zheng et al., 1999).
Scd1 was expressed in the LGR5 expressing mice, but the
expression pattern was slightly different from non-LGR5 expres-
sing mice. The altered expression pattern of Scd1 might contribute
to an alteration of the molecular components of the sebum and in
part explain the observed sparse fur coat of the LGR5 expressing
mice.
Inhibition of canonical Wnt signalling has been shown to
induce premature development of sebaceous glands and it is
possible that Wnt5a-mediated signalling might inhibit canonical
Wnt signalling (Han et al., 2006; Yuan et al., 2011). Non-canonical
Wnt signalling, mediated by Wnt5a, is known to result in Rho and
ROCK activation leading to elevated tissue stiffness and skin
hyperproliferation, resembling the LGR5-induced skin phenotype
described in the present study (Habas et al., 2003; Samuel et al.,
2011). In addition, we observed an increase in the mRNA levels of
Wnt5a and Gli1, the major effector of the Hh pathway, in the LGR5-
expressing skin. The exact mechanisms behind this increase in Gli1
mRNA are not fully understood; however, Wnt5a expression is
positively regulated by the Hh pathway in developing HFs (Reddyet al., 2001), suggesting that the increased Gli1 mRNA levels may
have contributed to the rise in Wnt5a mRNA levels in LGR5-
expressing skin.
Another contributing factor to the sparse fur phenotype could
be the fact that the number of HFs in embryonic skin was sig-
niﬁcantly reduced in LGR5-expressing embryos compared to WT.
However, a signiﬁcant increase in interfollicular distance was not
observed in adult mice. This observation might indicate delayed
HF development if smaller HFs were not apparent on the
embryonic cross-sections. The kink tail phenotype was irreversible
following arrested LGR5 expression, suggesting that permanent
damage had been caused to the tail vertebra. An association
between absent tail skin HFs and kink tail development with
permanent damage to tail vertebra has been reported previously
(Heath et al., 2009). The tail skin of the LGR5-expressing mice did
contain HFs, but it is possible that the ability of the HFs to expand
the epidermis might be impaired thus contributing to the kink tail
phenotype.
Rspos are ligands that bind to LGR5 and result in enhanced
canonical and non-canonical Wnt signalling (Carmon et al., 2011;
de Lau et al., 2011; Glinka et al., 2011). In the current study, Rspo1,
2 and 4 mRNA levels were upregulated signiﬁcantly in LGR5
expressing skin. In a mouse model, elevated Rspo1 levels have
been shown to result in crypt cell proliferation in the intestine
(Kim et al., 2005), while in dogs, increased Rspo2 levels were
associated with the "furnishing" phenotype-extra fur around the
J.H. Norum et al. / Developmental Biology 404 (2015) 35–48 47mouth and eyes (Cadieu et al., 2009). At E15.5, Rspo4 is expressed
at the site of mouse nail development and the RSPO4 gene is
mutated in inherited anonychia (the absence of nails; Blaydon
et al., 2006). Increased Rspo levels in the skin might, via over-
expression of the LGR5 receptor, contribute towards the
enhancement of Wnt5a-mediated signalling thus adding to the
phenotypic changes in LGR5-expressing mice.
K6þ cells were present in the IRS and IFE of the LGR5-
expressing mice, and the K6 antibody stained the IRS as expected.
It has been suggested that K6þ cells originate from Lgr5þ cells
residing in the lower outer root sheath (ORS) and Hopxþ cells
residing in the lower hair bulb (Hsu et al., 2011; Takeda et al.,
2013). Since it is known that K6 expression is induced under
hyperproliferative conditions in the IFE (Mansbridge and Knapp,
1987), the increased levels of K6þ and Ki67þ cells in the IFE of
LGR5-expressing skin, can be taken as signs of LGR5-mediated
hyperproliferation of the IFE.Conclusion
This is the ﬁrst report of a conditional and inducible transgenic
mouse strain expressing LGR5 under the control of a tetracycline
responsive element. We have demonstrated that expression of the
transgene LGR5 can be directed to different tissues depending on
the choice of promoter driving expression of the required trans-
activator. Our data showed that increased expression of LGR5 in
K5þ cells during embryogenesis and early development altered
skin development and caused several phenotypic changes,
including reduced body mass, sparse fur, kink tail and accelerated
maturation of sebocytes.
The conditional and inducible LGR5-expressing mice described
in the current study, together with the recently published Lgr5
knock-out mice (Kinzel et al., 2014) provide novel tools to explore
further the functional role of the Lgr5 receptor in development,
tissue homeostasis and carcinogenesis. LGR5 expression can be
induced in the tissue or cell type of interest, enabling functional
studies of this stem cell marker under numerous conditions.Acknowledgements
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